Descriptive statistics of the percentage change in tumor size from baseline or nadir to follow-up examination (assigned per clinical protocol) for each response assessment classification per tumor measurement strategy
TRC | Mean (%) | Standard Deviation (%) | Minimum (%) | Maximum (%) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CPc | CPsa | Vol1 | Vol2 | CPc | CPsa | Vol1 | Vol2 | CPc | CPsa | Vol1 | Vol2 | CPc | CPsa | Vol1 | Vol2 | |
PD | 57 | 83 | 75 | 79 | 64 | 78 | 81 | 59 | 27 | 18 | 9 | 42 | 227 | 224 | 271 | 271 |
SD | 6 | 14 | 16 | 8 | 13 | 28 | 32 | 20 | -27 | -68 | -73 | 51 | 25 | 91 | 83 | 39 |
Note:—CPc indicates clinical cross-product; CPsa, semiautomated cross-product; Vol1, volume (25/50% tumor response criteria); Vol2, volume (40/65% tumor response criteria).